<DOC>
	<DOC>NCT00730431</DOC>
	<brief_summary>The purpose of this study is to obtain single dose safety and pharmacokinetic (PK) data of IDX184 in humans. No formal hypotheses are to be tested in this study.</brief_summary>
	<brief_title>Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Participants are in general good health. All participants of childbearing potential must have agreed to use a consistent form of an acceptable doublebarrier method of birth control Participant is pregnant or breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Hepatitis C, healthy volunteers</keyword>
</DOC>